Positionally Modified siRNA Constructs for Gene Silencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for modulating gene expression using oligomeric compounds face challenges in achieving efficient and specific silencing of target genes, particularly in terms of structural requirements and stability, as existing compounds may not effectively hybridize with nucleic acids due to modifications that affect activity.

Innovation Solution

Development of oligomeric compounds comprising modified ribofuranosyl nucleosides at specific positions, such as 4′-thio or 2′-O-methyl nucleosides, which enhance hybridization properties and stability, allowing for effective targeting and modulation of gene expression by hybridizing with nucleic acids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If oligomeric compounds are modified with ribofuranosyl nucleosides to enhance stability, then compound stability is improved, but hybridization efficiency may be compromised

Engineering Contradiction:
Improvecompound stabilityVSAvoidhybridization efficiency
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent applies local quality by selectively modifying only specific nucleosides within the oligomeric compound at defined positions (such as 5', 3', or internal positions) while leaving other nucleosides unmodified. This allows the compound to have enhanced stability at modified positions while maintaining hybridization efficiency at the binding interface, resolving the contradiction between overall stability and hybridization efficiency.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the chemical parameters of specific nucleosides by incorporating modified ribofuranosyl nucleosides with different sugar modifications (e.g., 2'-O-methyl, 2'-fluoro, 4'-thio) at specific positions. These parameter changes enhance the structural stability and nuclease resistance of the oligomeric compound while the positioning and selection of modifications ensure that hybridization efficiency is maintained or improved.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If modifications are introduced at defined positions to enhance properties, then compound effectiveness is improved, but structural complexity increases

Engineering Contradiction:
Improvecompound effectivenessVSAvoidstructural complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Instead of uniformly modifying all nucleosides, the patent applies local quality by introducing modifications only at specific defined positions within the oligomeric compound. This selective approach enhances compound effectiveness through strategic modification while avoiding the unnecessary complexity that would result from comprehensive modification of all positions.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of modified ribofuranosyl nucleosides in oligomeric compounds improves their ability to hybridize with nucleic acids, leading to enhanced gene silencing efficacy and stability, facilitating specific modulation of gene expression.

Implementation Method 1

one of the strands capable of hybridizing to a nucleic acid target

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS8394947B2Positionally modified siRNA constructs
Publication Date: 2013.03.12 IONIS PHARMACEUTICALS INC
  • US8394947B2 patent drawing
  • US8394947B2 patent drawing
  • US8394947B2 patent drawing

AI summary

The present invention provides oligomeric compounds having sufficient complementarity to hybridize to a nucleic acid target and methods for their use in modulating gene expression. In one embodiment the oligomeric compounds comprise double stranded constructs wherein one of the strands capable of hybridizing to a nucleic acid target, and has a plurality of modified ribofuranosyl nucleosides at defined locations. The presence of modifications at such defined positions greatly enhances the properties of the corresponding compositions.